L. Frenkel

发表

Antiretroviral prophylaxis for HIV prevention in heterosexual men and women.

James D. Campbell, J. Baeten, J. Tappero, 2012, The New England journal of medicine.

Evolutionary Indicators of Human Immunodeficiency Virus Type 1 Reservoirs and Compartments

D. Nickle, M. Jensen, D. Shriner, 2003, Journal of Virology.

Potential limitation of CCR 5 antagonists : drug resistance more often linked to CXCR 4-utilizing than to CCR 5-utilizing HIV-1

L. Frenkel, Thor Wagner, Thor A Wagner, 2008 .

The management of pregnancies complicated by genital infections with herpes simplex virus.

L. Corey, C. Prober, L. Frenkel, 1992, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Viremia in neonatal herpes simplex virus infections.

L. Corey, L. Frenkel, K. Mohan, 1999, The Pediatric infectious disease journal.

Efficacy and safety of dolutegravir with emtricitabine and tenofovir alafenamide fumarate or tenofovir disoproxil fumarate, and efavirenz, emtricitabine, and tenofovir disoproxil fumarate HIV antiretroviral therapy regimens started in pregnancy (IMPAACT 2010/VESTED): a multicentre, open-label, rando

J. Stringer, P. Sax, S. Lockman, 2021, The Lancet.

Raltegravir versus efavirenz in antiretroviral-naive pregnant women living with HIV (NICHD P1081): an open-label, randomised, controlled, phase 4 trial.

P. Cahn, G. Siberry, E. Joao, 2020, The lancet. HIV.

Density-Dependent Decay in HIV-1 Dynamics

James I Mullins, J. Mullins, N. Tobin, 2006, Journal of acquired immune deficiency syndromes.

Cost-effectiveness analysis of pre-ART HIV drug resistance testing in Kenyan women

Ingrid A. Beck, R. Shafer, L. Garrison, 2020, EClinicalMedicine.

Variable and suboptimal nevirapine levels in infants given single-dose nevirapine at birth without maternal prophylaxis.

Ingrid A. Beck, E. Capparelli, L. Frenkel, 2014, AIDS.

Growth velocity assessment in paediatric AIDS: smoothing, penalized quantile regression and the definition of growth failure

V. Carey, V. Carey, L. Frenkel, 2004, Statistics in medicine.

Correlation of clinical progression in human immunodeficiency virus-infected children with in vitro zidovudine resistance measured by a direct quantitative peripheral blood lymphocyte assay.

M. Sim, L. Frenkel, E. R. Stiehm, 1995, The Journal of infectious diseases.

Effects of zidovudine use during pregnancy on resistance and vertical transmission of human immunodeficiency virus type 1.

S. Dewhurst, L. Demeter, R. Reichman, 1995, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

and S didanosine . associated with resistance to zidovudine and immunodeficiency virus type 1 pol mutations Specific , sensitive , and rapid assay for human

Dewhurst, L. Frenkel, T. Cummins, 1995 .

Clinical Significance of HIV-1 Drug Resistance Mutations

L. Frenkel, Thor Wagner, Thor A Wagner, 2006 .

Emerging antiretroviral drug resistance in sub-Saharan Africa: novel affordable technologies are needed to provide resistance testing for individual and public health benefits.

J. Nachega, J. Mellors, G. V. Van Zyl, 2014, AIDS.

Improved Detection of Rare HIV-1 Variants using 454 Pyrosequencing

Dylan H. Westfall, Ingrid A. Beck, J. Mullins, 2013, PloS one.

A search for persistent rubella virus infection in persons with chronic symptoms after rubella and rubella immunization and in patients with juvenile rheumatoid arthritis.

J. Wolinsky, J. Cherry, L. Frenkel, 1996, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Treatment of Cytomegalovirus Retinopathy in Patients With Acquired Immunodeficiency Syndrome: Use of the Experimental Drug 9-[2-Hydroxy-1-(hydroxymethyl)ethoxymethyl]guanine

L. Frenkel, G. Holland, A. Kreiger, 1986 .

Understanding HIV-1 drug resistance.

N. Tobin, L. Frenkel, Nicole H. Tobin, 2004, Therapeutic drug monitoring.

Correlation between Plasma, Intracellular, and Cervical Tissue Levels of Raltegravir at Steady-State Dosing in Healthy Women

C. Fletcher, Theodore J. Cory, C. Mitchell, 2014, Antimicrobial Agents and Chemotherapy.

Detection and quantification of multiple drug resistance mutations in HIV-1 reverse transcriptase by an oligonucleotide ligation assay.

S. Osmanov, L. Pérez-Alvárez, R. Nájera, 2001, Journal of human virology.

Detection of nonnucleoside reverse-transcriptase inhibitor-resistant HIV-1 after discontinuation of virologically suppressive antiretroviral therapy.

C. B. Hare, D. Havlir, J. Mellors, 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Sieve analysis of breakthrough HIV-1 sequences in HVTN 505 identifies vaccine pressure targeting the CD4 binding site of Env-gp120

Lindsay N. Carpp, Allan C. deCamp, Jerome H. Kim, 2017, PloS one.

Oligonucleotide Ligation Assay for Detecting Mutations in the Human Immunodeficiency Virus Type 1 polGene That Are Associated with Resistance to Zidovudine, Didanosine, and Lamivudine

D. Nickerson, V. Tobe, L. Frenkel, 1998, Journal of Clinical Microbiology.

Multiple High-Risk HPV Types Contribute to Cervical Dysplasia in Ugandan Women Living With HIV on Antiretroviral Therapy

L. Frenkel, J. Orem, S. Adams, 2022, Journal of acquired immune deficiency syndromes.

Treatment of cytomegalovirus retinopathy with ganciclovir.

M. Gottlieb, J. Cherry, R. Champlin, 1987, Ophthalmology.

Associations Between Genital Tract Infections, Genital Tract Inflammation, and Cervical Cytobrush HIV-1 DNA in US Versus Kenyan Women

S. Cohn, C. Cohen, J. Hitti, 2013, Journal of acquired immune deficiency syndromes.

Diminished Human Immunodeficiency Virus Type 1 DNA Yield from Dried Blood Spots after Storage in a Humid Incubator at 37°C Compared to −20°C

Ingrid A. Beck, G. Aldrovandi, J. Fitzgibbon, 2008, Journal of Clinical Microbiology.

The clinical implications of pretreatment drug resistance -- a moving target.

R. Shafer, L. Frenkel, 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Pretreatment HIV Drug Resistance and Virologic Outcomes to First-Line Antiretroviral Therapy in Peru.

Ingrid A. Beck, E. Ticona, S. León, 2019, AIDS research and human retroviruses.

Biomarkers of inflammation in HIV-infected Peruvian men and women before and during suppressive antiretroviral therapy

E. Ticona, J. Soria, C. Mitchell, 2015, AIDS.

Maternal syphilis and vertical perinatal transmission of human immunodeficiency virus type‐1 infection

R. Hallmark, L. Frenkel, G. del Priore, 1998, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

Persistence of Human Immunodeficiency Virus Type 1 Subtype B DNA in Dried-Blood Samples on FTA Filter Paper

Ingrid A. Beck, Chung-Chen Li, L. Frenkel, 2004, Journal of Clinical Microbiology.

Simple, Sensitive, and Specific Detection of Human Immunodeficiency Virus Type 1 Subtype B DNA in Dried Blood Samples for Diagnosis in Infants in the Field

Ingrid A. Beck, L. Frenkel, A. Herz, 2001, Journal of Clinical Microbiology.

Short Communication: Analysis of Minor Populations of Human Immunodeficiency Virus by Primer Identification and Insertion-Deletion and Carry Forward Correction Pipelines.

R. Coombs, L. Frenkel, Wenjie Deng, 2016, AIDS research and human retroviruses.

Resistance detected by pyrosequencing following zidovudine monotherapy for prevention of HIV-1 mother-to-child-transmission

Roger E Bumgarner, Ingrid A. Beck, J. Mullins, 2015, AIDS.

Oligonucleotide Ligation Assay Detects HIV Drug Resistance Associated With Virologic Failure Among Antiretroviral-Naive Adults in Kenya

Ingrid A. Beck, J. Overbaugh, B. Richardson, 2014, Journal of acquired immune deficiency syndromes.

Cytomegalovirus and Epstein–Barr virus in breast milk are associated with HIV-1 shedding but not with mastitis

D. Katzenstein, G. Woelk, L. Zijenah, 2008, AIDS (London).

Maternal viral genotypic zidovudine resistance and infrequent failure of zidovudine therapy to prevent perinatal transmission of human immunodeficiency virus type 1 in pediatric AIDS Clinical Trials Group Protocol 076.

R. Sperling, R. Coombs, L. Frenkel, 1998, The Journal of infectious diseases.

Validation of an Oligonucleotide Ligation Assay for Quantification of Human Immunodeficiency Virus Type 1 Drug-Resistant Mutants by Use of Massively Parallel Sequencing

Roger E Bumgarner, Ingrid A. Beck, J. Mullins, 2014, Journal of Clinical Microbiology.

Effect of Cessation of Zidovudine Prophylaxis to Reduce Vertical Transmission on Maternal HIV Disease Progression and Survival

L. Mofenson, R. Sperling, M. Fowler, 2003, Journal of acquired immune deficiency syndromes.

Pre-treatment HIV-drug resistance associated with virologic outcome of first-line NNRTI-antiretroviral therapy: A cohort study in Kenya

Ingrid A. Beck, B. Chohan, J. Kiarie, 2020, EClinicalMedicine.

Evaluation of the management of pretreatment HIV drug resistance by oligonucleotide ligation assay: a randomised controlled trial.

Ingrid A. Beck, B. Chohan, J. Kiarie, 2019, The lancet. HIV.

Predictors of mortality within the first year of initiating antiretroviral therapy in urban and rural Kenya: A prospective cohort study

Ingrid A. Beck, B. Chohan, B. Richardson, 2019, PloS one.

The Burden of HIV Associated Drug Resistance Mutations in an Early Infant Diagnosis Program: A Glance through the Paediatric Window of Zimbabwe

Ingrid A. Beck, M. T. Manhanzva, L. Frenkel, 2016 .

Cross-contamination during processing of dried blood spots used for rapid diagnosis of HIV-1 infection of infants is rare and avoidable.

C. Mitchell, L. Frenkel, Do Peterson, 2010, Journal of virological methods.

Detection and Quantification of Human Immunodeficiency Virus Type 1 p24 Antigen in Dried Whole Blood and Plasma on Filter Paper Stored under Various Conditions

Chung-Chen Li, R. Coombs, L. Frenkel, 2005, Journal of Clinical Microbiology.

Risk of drug resistance among persons acquiring HIV within a randomized clinical trial of single- or dual-agent preexposure prophylaxis.

Frederick Albert Matsen IV, J. Baeten, J. Overbaugh, 2015, The Journal of infectious diseases.

The epidemiology of pediatric HIV-1 infection.

L. Frenkel, P. Annunziato, 1993, Pediatric annals.

Impact of Tenofovir-Based Pre-exposure Prophylaxis on Biomarkers of Bone Formation, Bone Resorption, and Bone Mineral Metabolism in HIV-Negative Adults

J. Baeten, R. Heffron, A. Branch, 2019, Open forum infectious diseases.

Monotypic low-level HIV viremias during antiretroviral therapy are associated with disproportionate production of X4 virions and systemic immune activation

E. Acosta, E. Ticona, J. Soria, 2018, AIDS.

Comparisons of Human Immunodeficiency Virus Type 1 Envelope Variants in Blood and Genital Fluids near the Time of Male-to-Female Transmission

J. Mullins, H. Rees, A. Wald, 2019, Journal of Virology.

HIV Transmission Through Premastication.

L. Frenkel, A. Melvin, M. Hirschfeld, 2022, Pediatrics.

Genital shedding of human immunodeficiency virus type-1 (HIV) when antiretroviral therapy (ART) suppresses HIV replication in the plasma.

E. Acosta, E. Ticona, J. Soria, 2020, The Journal of infectious diseases.

Single-agent tenofovir versus combination emtricitabine plus tenofovir for pre-exposure prophylaxis for HIV-1 acquisition: an update of data from a randomised, double-blind, phase 3 trial.

J. Baeten, J. Tappero, D. Bangsberg, 2014, The Lancet. Infectious diseases.

Food insecurity, drug resistance and non-disclosure are associated with virologic non-suppression among HIV pregnant women on antiretroviral treatment

Jennifer A. Unger, Alison L. Drake, Ingrid A. Beck, 2021, PloS one.

Extensive characterization of HIV-1 reservoirs reveals links to plasma viremia before and during analytical treatment interruption.

T. Schlub, L. Vandekerckhove, L. Frenkel, 2022, Cell reports.

In-depth characterization of HIV-1 reservoirs reveals links to viral rebound during 1 treatment interruption 2

Sherry, T. Schlub, L. Vandekerckhove, 2021 .

Monotypic Human Immunodeﬁciency Virus Type 1 Genotypes across the Uterine Cervix and in Blood Suggest Proliferation of Cells with Provirus (cid:1)

G. Learn, J. Mullins, J. Hitti, 2009 .

Efficacy and toxicity of antiretroviral therapy using 4 or more agents: application of a strategy for antiretroviral management in human immunodeficiency virus-infected children.

L. Frenkel, K. Mohan, A. Melvin, 2002, Archives of pediatrics & adolescent medicine.

Efficacy and Toxicity of Antiretroviral Therapy Using 4 or More Agents: Application of a Strategy for Antiretroviral Management in Human Immunodeficiency VirusInfected Children

L. Frenkel, K. Mohan, A. Melvin, 2002 .

The effects of zidovudine in the subset of infants infected with human immunodeficiency virus type-1 (Pediatric AIDS Clinical Trials Group Protocol 076).

N. McGrath, R. Sperling, R. Coombs, 1999, The Journal of pediatrics.

Safety and efficacy at 240 weeks of different raltegravir formulations in children with HIV-1: a phase 1/2 open label, non-randomised, multicentre trial.

H. Teppler, A. Rodgers, S. Nachman, 2018, The lancet. HIV.

Pharmacokinetics and 48-Week Safety and Efficacy of Raltegravir for Oral Suspension in Human Immunodeficiency Virus Type-1-Infected Children 4 Weeks to 2 Years of Age.

S. Spector, H. Teppler, E. Acosta, 2015, Journal of the Pediatric Infectious Diseases Society.

Pharmacokinetics, safety, and 48-week efficacy of oral raltegravir in HIV-1-infected children aged 2 through 18 years.

S. Spector, H. Teppler, E. Acosta, 2014, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

HIV Transmission During Condomless Sex With a Seropositive Partner With Suppressed Infection.

J. Mullins, J. Goldman, L. Frenkel, 2016, JAMA.

Preexposure prophylaxis is efficacious for HIV-1 prevention among women using depot medroxyprogesterone acetate for contraception

J. Baeten, R. Heffron, E. Bukusi, 2014, AIDS.

Simultaneous and sensitive detection of human immunodeficiency virus type 1 (HIV) drug resistant genotypes by multiplex oligonucleotide ligation assay.

Ingrid A. Beck, L. Frenkel, L. Vaz, 2013, Journal of virological methods.

Selection of HIV Resistance Associated With Antiretroviral Therapy Initiated Due to Pregnancy and Suspended Postpartum

J. Hitti, L. Frenkel, Giovanina M. Ellis, 2011, Journal of acquired immune deficiency syndromes.

Optimization of the oligonucleotide ligation assay for the detection of nevirapine resistance mutations in Zimbabwean Human Immunodeficiency Virus type-1 subtype C.

T. Chipato, L. Stranix-Chibanda, M. T. Manhanzva, 2014, Journal of virological methods.

Herpes simplex virus type 2 suppressive therapy with acyclovir or valacyclovir does not select for specific HIV-1 resistance in HIV-1/HSV-2 dually infected persons.

Ingrid A. Beck, J. Baeten, A. Wald, 2011, The Journal of infectious diseases.

Intrapartum tenofovir and emtricitabine reduces low-concentration drug resistance selected by single-dose nevirapine for perinatal HIV prevention.

B. Chi, J. Stringer, G. Aldrovandi, 2009, AIDS research and human retroviruses.

HIV type 1 zidovudine (ZDV) resistance in blood and uterine cervical secretions of pregnant women.

D. H. Watts, J. Hitti, E. Cooper, 2006, AIDS research and human retroviruses.

Comparison of Oligonucleotide Ligation Assay and Consensus Sequencing for Detection of Drug-Resistant Mutants of Human Immunodeficiency Virus Type 1 in Peripheral Blood Mononuclear Cells and Plasma

Ingrid A. Beck, Chung-Chen Li, L. Frenkel, 2004, Journal of Clinical Microbiology.

Two Clusters of HIV-1 Infection, Rural Idaho, USA, 2008

L. Frenkel, C. Hahn, Giovanina M. Ellis, 2010, Emerging infectious diseases.

Current Status of Point‐of‐Care Testing for Human Immunodeficiency Virus Drug Resistance

Iain J. MacLeod, James J. Lai, Ingrid A. Beck, 2017, The Journal of infectious diseases.

Implementation of a point mutation assay for HIV drug resistance testing in Kenya

Ingrid A. Beck, B. Chohan, L. Frenkel, 2018, AIDS.

Polymerase chain reaction diagnosis of primary human herpesvirus-6 infection in the acute care setting.

M. D. Del Beccaro, L. Corey, Meei-Li W Huang, 2006, The Journal of pediatrics.

Primary human herpesvirus‐6 associated with an afebrile seizure in a 3‐week‐old infant

L. Corey, Meei-Li W Huang, L. Frenkel, 2002, Journal of medical virology.

Maternal Toxicity With Continuous Nevirapine in Pregnancy: Results From PACTG 1022

Lee-Jen Wei, D. H. Watts, J. Hitti, 2004, Journal of acquired immune deficiency syndromes.

H1N1 influenza vaccination in HIV-infected women on effective antiretroviral treatment did not induce measurable antigen-driven proliferation of the HIV-1 proviral reservoir

S. Nachman, L. Frenkel, A. Weinberg, 2017, AIDS Research and Therapy.

Challenges in the Diagnosis and Management of Neonatal Herpes Simplex Virus Encephalitis

L. Frenkel, 2005, Pediatrics.

Drug Resistance Working Group. AIDS Clinical Trials Group Virology Committee virus type 1 drug resistance mutation. The reaction to detect a human immunodeficiency sequence-specific PCR and ligase detection Interlaboratory comparison of

R. Shafer, D. Kuritzkes, M. Winters, 2013 .

Interlaboratory comparison of sequence-specific PCR and ligase detection reaction to detect a human immunodeficiency virus type 1 drug resistance mutation. The AIDS Clinical Trials Group Virology Committee Drug Resistance Working Group

R. Shafer, D. Kuritzkes, A. Iversen, 1996, Journal of clinical microbiology.

Oral ganciclovir in children: pharmacokinetics, safety, tolerance, and antiviral effects. The Pediatric AIDS Clinical Trials Group.

W. Borkowsky, S. Spector, R. Yogev, 2000, The Journal of infectious diseases.

Pre-exposure prophylaxis for HIV-negative persons with partners living with HIV: uptake, use, and effectiveness in an open-label demonstration project in East Africa

J. Baeten, R. Heffron, E. Katabira, 2017, Gates open research.

Pre-exposure prophylaxis for HIV-negative persons with partners living with HIV: uptake, use, and effectiveness in an open-label demonstration project in East Africa.

J. Baeten, R. Heffron, E. Katabira, 2017, Gates open research.

Transmission of nevirapine-resistant HIV type 1 via breast milk to infants after single-dose nevirapine in Beira, Mozambique.

Ingrid A. Beck, L. Frenkel, S. Gloyd, 2014, The Journal of infectious diseases.

Case of concurrent influenza A and Kawasaki disease

L. Frenkel, Vijaya L. Soma, N. Moss, 2015 .

Lack of detection of human immunodeficiency virus type 1 in the saliva of infected children and adolescents.

L. Frenkel, S. Burchett, R. Cone, 1997, Archives of pediatrics & adolescent medicine.

A search for persistent measles, mumps, and rubella vaccine virus in children with human immunodeficiency virus type 1 infection.

J. Cherry, L. Frenkel, K. Nielsen, 1994, Archives of pediatrics & adolescent medicine.

Advances in antiviral therapy.

L. Frenkel, D. Zerr, 1999, Current opinion in pediatrics.

Rapid decline of neutralizing antibodies is associated with decay of IgM in adults recovered from mild COVID-19

Samantha J. Hardy, D. Sather, Yonghou Jiang, 2021, Cell Reports Medicine.

Plasma from recovered COVID19 subjects inhibits spike protein binding to ACE2 in a microsphere-based inhibition assay

D. Sather, V. Vigdorovich, L. Frenkel, 2020, medRxiv.

Recurrent Bipolaris sinusitis following surgical and antifungal therapy.

J. Cherry, L. Frenkel, D. Howard, 1987, The Pediatric infectious disease journal.

Treatment of cytomegalovirus retinopathy in patients with acquired immunodeficiency syndrome. Use of the experimental drug 9-[2-hydroxy-1-(hydroxymethyl)ethoxymethyl]guanine.

L. Frenkel, G. Holland, A. Kreiger, 1987, Archives of ophthalmology.

Ontogeny of phytohemagglutinin-induced gamma interferon by leukocytes of healthy infants and children: evidence for decreased production in infants younger than 2 months of age.

L. Frenkel, Y. Bryson, 1987, The Journal of pediatrics.

Oral acyclovir suppression and neurodevelopment after neonatal herpes.

D. Powell, P. Sánchez, G. Storch, 2011, The New England journal of medicine.

Pharmacokinetics of Dapsone Administered Daily and Weekly in Human Immunodeficiency Virus-Infected Children

J. Lindsey, L. Mofenson, V. Bonagura, 1999, Antimicrobial Agents and Chemotherapy.

Histoplasmosis after multiple trauma.

L. Frenkel, D. Howard, M. M. Stone, 1990, The Pediatric infectious disease journal.

Intravenous immune globulin for the prevention of bacterial infections in children with symptomatic human immunodeficiency virus infection.

L. Mofenson, V. Bonagura, P. Edelson, 1991, The New England journal of medicine.

Natural history of neonatal herpes simplex virus infections in the acyclovir era.

S. Soong, D. Powell, W. Gruber, 2001, Pediatrics.

Risk of congenital cytomegalovirus infection among HIV‐exposed uninfected infants is not decreased by maternal nelfinavir use during pregnancy

E. Leister, Meei-Li W Huang, K. Jerome, 2016, Journal of medical virology.

Pharmacokinetics of acyclovir in the term human pregnancy and neonate.

L. Corey, J. Connor, J. Unadkat, 1991, American journal of obstetrics and gynecology.

Effects of short-course zidovudine on the selection of nevirapine-resistant HIV-1 in women taking single-dose nevirapine.

Ingrid A. Beck, L. Frenkel, S. Gloyd, 2012, The Journal of infectious diseases.

A population-based study of primary human herpesvirus 6 infection.

A. Wald, A. Meier, L. Corey, 2005, The New England journal of medicine.

Effect of food and pharmacokinetic variability on didanosine systemic exposure in HIV-infected children. Pediatric AIDS Clinical Trials Group Protocol 144 Study Team.

V. Carey, J. Rodman, L. Frenkel, 2000, AIDS research and human retroviruses.

Development and validation of an oligonucleotide ligation assay to detect lamivudine resistance in hepatitis B virus.

Ingrid A. Beck, L. Frenkel, N. Ngo-Giang-Huong, 2016, Journal of virological methods.

Highly active antiretroviral treatment (HAART) of pediatric HIV-1 infection

Nicole Tobin, L. Frenkel, 2004 .

Transmitted HIV resistance to first-line antiretroviral therapy in Lima, Peru.

E. Ticona, J. Soria, C. Mitchell, 2012, AIDS research and human retroviruses.

Association between detection of HIV-1 DNA resistance mutations by a sensitive assay at initiation of antiretroviral therapy and virologic failure.

F. Fregonese, L. Frenkel, V. Klinbuayaem, 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Nevirapine resistance by timing of HIV type 1 infection in infants treated with single-dose nevirapine.

Ingrid A. Beck, L. Frenkel, S. Gloyd, 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Rapid and Sensitive Oligonucleotide Ligation Assay for Detection of Mutations in Human Immunodeficiency Virus Type 1 Associated with High-Level Resistance to Protease Inhibitors

Ingrid A. Beck, L. Frenkel, M. Mahalanabis, 2002, Journal of Clinical Microbiology.

A comparison of 3 regimens to prevent nevirapine resistance mutations in HIV-infected pregnant women receiving a single intrapartum dose of nevirapine.

Ingrid A. Beck, T. Puthanakit, L. Frenkel, 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Efficacy and safety of 1-month postpartum zidovudine-didanosine to prevent HIV-resistance mutations after intrapartum single-dose nevirapine.

K. Mcintosh, L. Frenkel, I. Collins, 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Current management of HIV infection in children.

T. Cvetkovich, L. Frenkel, 1993, Pediatric annals.

A proof-of-concept study of short-cycle intermittent antiretroviral therapy with a once-daily regimen of didanosine, lamivudine, and efavirenz for the treatment of chronic HIV infection.

Ingrid A. Beck, M. Dybul, R. Dewar, 2004, The Journal of infectious diseases.

Pharmacokinetics and safety of stavudine in HIV-infected pregnant women and their infants: Pediatric AIDS Clinical Trials Group protocol 332.

L. Mofenson, J. Hitti, J. Unadkat, 2004, The Journal of infectious diseases.

Prevalence of Pre-antiretroviral-Treatment Drug Resistance by Gender, Age, and Other Factors in HIV-Infected Individuals Initiating Therapy in Kenya, 2013–2014

Ingrid A. Beck, B. Chohan, B. Richardson, 2017, The Journal of infectious diseases.

Minority and majority pre-treatment HIV-1 drug resistance associated with failure of 1st-line NNRTI ART in Kenyan women.

Ingrid A. Beck, J. Kiarie, R. Coombs, 2019, AIDS.

Simplified Paper Format for Detecting HIV Drug Resistance in Clinical Specimens by Oligonucleotide Ligation

Ingrid A. Beck, B. Lutz, J. Kiarie, 2016, PloS one.

HIV drug resistance in mothers and infants following use of antiretrovirals to prevent mother-to-child transmission.

L. Frenkel, Quy T Ton, 2013, Current HIV research.

Prevalence and Impact of Minority Variant Drug Resistance Mutations in Primary HIV-1 Infection

Lisa M. Frenkel, A. Collier, L. Frenkel, 2011, PloS one.

Antiretroviral treatment for HIV-infected infants exposed to nevirapine.

L. Frenkel, Thor A Wagner, 2010, JAMA.

Optimization of the Oligonucleotide Ligation Assay, a Rapid and Inexpensive Test for Detection of HIV-1 Drug Resistance Mutations, for Non-North American Variants

Ingrid A. Beck, Y. Shao, Sabelle Jallow, 2008, Journal of acquired immune deficiency syndromes.

Clinical, virologic and immunologic responses of children with advanced human immunodeficiency virus type 1 disease treated with protease inhibitors.

L. Frenkel, K. Mohan, A. Melvin, 1997, The Pediatric infectious disease journal.

OLA-Simple: A software-guided HIV-1 drug resistance test for low-resource laboratories

Parker S. Ruth, Justin D. Vrana, James J. Lai, 2019, EBioMedicine.

Detection of HIV-1 Drug Resistance in Women Following Administration of a Single Dose of Nevirapine: Comparison of Plasma RNA to Cellular DNA by Consensus Sequencing and by Oligonucleotide Ligation Assay

Ingrid A. Beck, L. Frenkel, Thor A Wagner, 2010, Journal of Clinical Microbiology.

HIV-1 RNA Levels and Antiretroviral Drug Resistance in Blood and Non-Blood Compartments from HIV-1–Infected Men and Women enrolled in AIDS Clinical Trials Group Study A5077

D. Katzenstein, R. D’Aquila, R. Bosch, 2014, PloS one.

Pediatric AIDS prognosis using somatic growth velocity

V. Carey, R. McKinney, L. Frenkel, 1998, AIDS.

HIV-1 drug resistance before initiation or re-initiation of first-line antiretroviral therapy in low-income and middle-income countries: a systematic review and meta-regression analysis

Tulio de Oliveira, Meg Doherty, Deenan Pillay, 2017, The Lancet. Infectious diseases.

Impact of CYP2B6 genotype, tuberculosis therapy, and formulation on efavirenz pharmacokinetics in infants and children under 40 months of age

S. Spector, E. Capparelli, L. Frenkel, 2021, AIDS.

Effect of pregnancy and zidovudine therapy on viral load in HIV-1-infected women.

J. Hughes, D. H. Watts, J. Hitti, 1997, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

Association of Virologic Failure and Nonnucleoside Reverse Transcriptase Inhibitor Resistance Found in Antiretroviral-Naive Children Infected With Human Immunodeficiency Virus and Given Efavirenz-Based Treatment.

Ingrid A. Beck, E. Capparelli, L. Frenkel, 2019, Journal of the Pediatric Infectious Diseases Society.

Genetic Analyses of HIV-1 env Sequences Demonstrate Limited Compartmentalization in Breast Milk and Suggest Viral Replication within the Breast That Increases with Mastitis

D. Katzenstein, J. Mullins, L. Heath, 2010, Journal of Virology.

Laboratory indicators of mastitis are not associated with elevated HIV-1 DNA loads or predictive of HIV-1 RNA loads in breast milk.

D. Katzenstein, G. Woelk, L. Zijenah, 2007, The Journal of infectious diseases.

Specific, sensitive, and rapid assay for human immunodeficiency virus type 1 pol mutations associated with resistance to zidovudine and didanosine

S. Dewhurst, L. Frenkel, L M Frenkel, 1995, Journal of clinical microbiology.

Pediatric HIV-1 infection.

L. Frenkel, A. Melvin, 1997, Obstetrics and gynecology clinics of North America.

Prevention of mother-to-infant transmission of HIV-1.

L. Frenkel, A. Melvin, L. Frenkel, 1997, Molecular medicine today.

Risk of mother-to-infant transmission of HIV-1 is not reduced in CCR5/delta32ccr5 heterozygotes.

J. Hughes, L. Frenkel, K. Mohan, 1997, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

Blinded, Multicenter Comparison of Methods To Detect a Drug-Resistant Mutant of Human Immunodeficiency Virus Type 1 at Low Frequency

Ingrid A. Beck, K. Metzner, V. Johnson, 2006, Journal of Clinical Microbiology.

Sensitive Method for Detection of Human Herpesviruses 6 and 7 in Saliva Collected in Field Studies

L. Corey, Meei-Li W Huang, L. Frenkel, 2000, Journal of Clinical Microbiology.

Clonal Expansion of Human Immunodeficiency Virus-Infected Cells and Human Immunodeficiency Virus Persistence During Antiretroviral Therapy.

J. Mullins, L. Frenkel, 2017, The Journal of infectious diseases.

A highly multiplexed droplet digital PCR assay to measure the intact HIV-1 proviral reservoir

J. Schiffer, M. Busch, S. Deeks, 2021, Cell reports. Medicine.

Proliferation of cells with HIV integrated into cancer genes contributes to persistent infection

Brendan B. Larsen, Lisa M. Frenkel, Paul T. Edlefsen, 2014, Science.

Effectiveness of antenatal group HIV voluntary counseling and testing services in rural India.

L. Frenkel, D. Gupta, R. Viswanath, 2007, AIDS education and prevention : official publication of the International Society for AIDS Education.

Human immunodeficiency viruses appear compartmentalized to the female genital tract in cross-sectional analyses but genital lineages do not persist over time.

J. Mullins, L. Heath, S. Cohn, 2013, The Journal of infectious diseases.

CRISPR/Cas9-Mediated Insertion of HIV Long Terminal Repeat within BACH2 Promotes Expansion of T Regulatory–like Cells

J. Mullins, D. Rawlings, L. Frenkel, 2022, Journal of Immunology.

Short Communication: Phylogenetic Evidence of HIV-1 Transmission Between Adult and Adolescent Men Who Have Sex with Men.

J. Herbeck, K. Thomas, Elizabeth R. Wolf, 2016, AIDS research and human retroviruses.

Methods used to examine compartmentalization of viral populations between the genital tract and peripheral blood.

G. Learn, J. Mullins, L. Frenkel, 2007, The Journal of infectious diseases.

Should patients with drug-resistant HIV-1 continue to receive antiretroviral therapy?

J. Mullins, L. Frenkel, Lisa M. Frenkel, 2001, The New England journal of medicine.

HIV-1 dynamics in children.

A. Rodrigo, J. Mullins, R. Coombs, 1999, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

Pandemic ( H 1 N 1 ) 2009 and Oseltamivir Resistance in Hematology / Oncology Patients

L. Frenkel, C. Hahn, Giovanina M. Ellis, 2019 .

Passive Transfer of HIV-1 Antibodies and Drug Resistant Virus during a Health Care Worker Accident: Implications for HCW Post-Exposure Management

G. Learn, J. Mullins, Phalguni Gupta, 2008 .

Healthy Neonates Possess a CD56-Negative NK Cell Population with Reduced Anti-Viral Activity

C. Mitchell, L. Frenkel, H. Horton, 2013, PloS one.

Cells producing residual viremia during antiretroviral treatment appear to contribute to rebound viremia following interruption of treatment

J. Mullins, A. Collier, R. Coombs, 2020, PLoS pathogens.

Comment on "The Origins of Sexually Transmitted HIV Among Men Who Have Sex with Men"

J. Mullins, B. Foley, L. Heath, 2010, Science Translational Medicine.

Interaction between lactobacilli, bacterial vaginosis-associated bacteria, and HIV Type 1 RNA and DNA Genital shedding in U.S. and Kenyan women.

S. Cohn, C. Cohen, J. Hitti, 2013, AIDS research and human retroviruses.

Genetic evaluation of suspected cases of transient HIV-1 infection of infants.

B L Herring, L. Hood, G. Learn, 1998, Science.

Cytomegalovirus gastropathy in a child: resolution after ganciclovir therapy.

A. Wald, L. Frenkel, D. Christie, 1998, Clinical Infectious Diseases.

HIV-1 Drug Resistance Mutations: Potential Applications for Point-of-Care Genotypic Resistance Testing

T. F. Rinke de Wit, D. Katzenstein, R. Shafer, 2015, PloS one.

Persistence of HIV drug resistance among South African children given nevirapine to prevent mother-to-child-transmission

Ingrid A. Beck, L. Frenkel, T. Rossouw, 2017, AIDS (London).

Planned multiple exposures to autologous virus in HIV type 1-infected pediatric populations increases HIV-specific immunity and reduces HIV viremia.

W. Borkowsky, R. Yogev, E. Capparelli, 2008, AIDS research and human retroviruses.

Loss to Follow-Up Among HIV-Exposed Children in an HIV Clinic in Beira, Mozambique

L. Frenkel, J. Pfeiffer, S. Gloyd, 2015 .

Near point-of-care, point-mutation test to detect drug resistance in HIV-1: a validation study in a Mexican cohort.

Parker S. Ruth, Ingrid A. Beck, S. Ávila-Ríos, 2020, AIDS.

Immune reconstitution after receipt of highly active antiretroviral therapy in children with advanced or progressive HIV disease and complete or partial viral load response.

G. Montepiedra, L. Mofenson, V. Carey, 2005, The Journal of infectious diseases.

Effects of CCR5-Δ32 and CCR2-64I alleles on disease progression of perinatally HIV-1-infected children: an international meta-analysis

J. Goedert, J. Ioannidis, P. Rosenberg, 2003, AIDS.

Postpartum Viral Load Rebound in HIV-1–Infected Women Treated with Highly Active Antiretroviral Therapy: AIDS Clinical Trials Group Protocol A5150

S. Kalams, F. Aweeka, S. Cohn, 2011, HIV clinical trials.

Increased Detection of HIV-1 Drug Resistance at Time of Diagnosis by Testing Viral DNA With a Sensitive Assay

S. Buskin, L. Page, L. Frenkel, 2009, Journal of acquired immune deficiency syndromes.

Importance and detection of virus reservoirs and compartments of HIV infection.

D. Nickle, D. Shriner, J. Mullins, 2003, Current opinion in microbiology.

Analysis of the maternal components of the AIDS clinical trial group 076 zidovudine regimen in the prevention of mother-to-infant transmission of human immunodeficiency virus type 1.

M. Cowles, D. H. Watts, L. Frenkel, 1997, The Journal of infectious diseases.

Genetic analyses of HIV env associated with uveitis in antiretroviral-naive individuals

K. Pathanapitoon, L. Frenkel, T. Samleerat, 2017, AIDS.

Association of Maternal Viral Load and CD4 Count With Perinatal HIV-1 Transmission Risk During Breastfeeding in the PROMISE Postpartum Component

Ingrid A. Beck, D. Moodley, L. Mofenson, 2021, Journal of acquired immune deficiency syndromes.

Brief Report: Vaginal Viral Shedding With Undetectable Plasma HIV Viral Load in Pregnant Women Receiving 2 Different Antiretroviral Regimens: A Randomized Clinical Trial

E. Joao, R. Coombs, L. Frenkel, 2021, Journal of acquired immune deficiency syndromes.

Extensive characterization of HIV-1 reservoirs reveals links to plasma viremia before and during analytical treatment interruption

T. Schlub, L. Vandekerckhove, L. Frenkel, 2021, bioRxiv.

Evidence that Low-Level Viremias during Effective Highly Active Antiretroviral Therapy Result from Two Processes: Expression of Archival Virus and Replication of Virus

Yang Wang, Gerald H. Learn, Sarah E. Holte, 2005, Journal of Virology.

An Increasing Proportion of Monotypic HIV-1 DNA Sequences during Antiretroviral Treatment Suggests Proliferation of HIV-Infected Cells

J. Mullins, N. Tobin, L. Frenkel, 2012, Journal of Virology.

Multiple Viral Genetic Analyses Detect Low-Level Human Immunodeficiency Virus Type 1 Replication during Effective Highly Active Antiretroviral Therapy

Yang Wang, Gerald H. Learn, Sarah E. Holte, 2003, Journal of Virology.

Phylogenetic Analyses Comparing HIV Sequences from Plasma at Virologic Failure to Cervix Versus Blood Sequences from Antecedent Antiretroviral Therapy Suppression.

J. Mullins, S. Cohn, J. Hitti, 2019, AIDS research and human retroviruses.

Single-Agent Tenofovir versus Combination Emtricitabine/ Tenofovir for Pre-Exposure Prophylaxis against HIV-1 Acquisition: A Randomized Trial

Jonathan, J. Tappero, D. Bangsberg, 2014 .

Compartmentalization of HIV-1 within the Female Genital Tract Is Due to Monotypic and Low-Diversity Variants Not Distinct Viral Populations

G. Learn, J. Mullins, J. Hitti, 2009, PloS one.

Simpler and faster Covid-19 testing: Strategies to streamline SARS-CoV-2 molecular assays

Parker S. Ruth, Justin D. Vrana, Ingrid A. Beck, 2021, EBioMedicine.

Inexpensive workflow for simultaneous monitoring of HIV viral load and detection of SARS-CoV-2 infection.

James J. Lai, Ingrid A. Beck, G. Gulati, 2021, medRxiv : the preprint server for health sciences.

Transmission Cluster of Multiclass Highly Drug-Resistant HIV-1 Among 9 Men Who Have Sex With Men in Seattle/King County, WA, 2005-2007

G. Gottlieb, S. Buskin, S. Pergam, 2008, Journal of acquired immune deficiency syndromes.

Pediatric AIDS: Clinical, Pathologic, and Basic Science Perspectives. Conference proceedings. Washington, D.C., November 18-21, 1992.

Boechat, R. Elashoff, R. Mellins, 1993, Annals of the New York Academy of Sciences.

Assessment of mitochondrial toxicity by analysis of mitochondrial protein expression in mononuclear cells

N. Tobin, K. Jerome, L. Frenkel, 2009, Cytometry. Part B, Clinical cytometry.

The In Vitro Growth and Serial Passage of RA 27/3 Rubella Vaccine Virus in Cord Blood Mononuclear Leukocytes from Normal Babies

J. Cherry, L. Frenkel, K. Nielsen, 1995, Pediatric Research.

CD101 genetic variants modify regulatory and conventional T cell phenotypes and functions

Corinne M. Mar, J. Mullins, J. Baeten, 2021, Cell reports. Medicine.

Immunization by exposure to live virus (SIVmne/HIV-2287) during antiretroviral drug prophylaxis may reduce risk of subsequent viral challenge

Ingrid A. Beck, D. Montefiori, Shiu-Lok Hu, 2021, PloS one.

Diagnostic Accuracy of Dried Plasma Spot Specimens for HIV-1 Viral Load Testing: A Systematic Review and Meta-analysis

Ingrid A. Beck, Y. Fong, J. Nelson, 2021, Journal of acquired immune deficiency syndromes.

Plasma From Recovered COVID-19 Patients Inhibits Spike Protein Binding to ACE2 in a Microsphere-Based Inhibition Assay

D. Sather, Yonghou Jiang, V. Vigdorovich, 2020, The Journal of infectious diseases.

Increased mutations in Env and Pol suggest greater HIV-1 replication in sputum-derived viruses compared with blood-derived viruses

G. Learn, J. Mullins, N. Tobin, 2009, AIDS.

Rapid HIV type 1 testing of women presenting in late pregnancy with unknown HIV status in Lima, Peru.

L. Frenkel, A. Melvin, Carlos Rodriguez, 2004, AIDS research and human retroviruses.

Pseudomonas folliculitis from sponges promoted as beauty aids

L. Frenkel, 1993, Journal of clinical microbiology.

Low rate of SARS-CoV-2 incident infection identified by weekly screening PCR in a prospective year-long cohort study

Samantha J. Hardy, Ingrid A. Beck, Fred D. Mast, 2022, PloS one.

Lack of Resistance to Integrase Inhibitors among Antiretroviral-Naive Subjects with Primary HIV-1 Infection, 2007–2013

J. Mullins, S. Buskin, A. Collier, 2015, Antiviral therapy.

Monotypic Human Immunodeficiency Virus Type 1 Genotypes across the Uterine Cervix and in Blood Suggest Proliferation of Cells with Provirus

Robert W. Coombs, Gerald H. Learn, Lisa M. Frenkel, 2009, Journal of Virology.

Transmission of HIV-1 drug resistance mutations within partner-pairs: A cross-sectional study of a primary HIV infection cohort

Ingrid A. Beck, J. Mullins, J. Herbeck, 2018, PLoS medicine.

Ethics of HIV research in children.

L. Frenkel, T. Rossouw, J. Crane, 2015, The Lancet. Infectious diseases.

Efficacy and safety of three antiretroviral therapy regimens started in pregnancy up to 50 weeks post partum: a multicentre, open-label, randomised, controlled, phase 3 trial.

P. Sax, S. Lockman, J. Currier, 2023, The lancet. HIV.

Correlates of HIV detection among breastfeeding postpartum Kenyan women eligible under Option B+

B. Chohan, A. Wald, J. Overbaugh, 2019, PloS one.

Nevirapine-Resistant HIV-1 DNA in Breast Milk After Single-Dose Nevirapine With or Without Zidovudine for Prevention of Mother-to-Child Transmission.

Ingrid A. Beck, L. Frenkel, S. Gloyd, 2012, Journal of the Pediatric Infectious Diseases Society.

Human T-lymphotropic virus type 1-associated myelopathy/tropical spastic paraparesis: Viral load and muscle tone are correlated

W. Longstreth, J. Zunt, L. Frenkel, 2006, Journal of NeuroVirology.

Comparison of Matrix-Based and Filter Paper-Based Systems for Transport of Plasma for HIV-1 RNA Quantification and Amplicon Preparation for Genotyping

Ingrid A. Beck, L. Frenkel, G. Pepper, 2016, Journal of Clinical Microbiology.

Human immunodeficiency virus drug susceptibility and resistance testing.

N. Tobin, L. Frenkel, Nicole H. Tobin, 2002, The Pediatric infectious disease journal.

Low concentrations of HIV-1 DNA at birth delays diagnosis, complicating identification of infants for antiretroviral therapy to potentially prevent the establishment of viral reservoirs.

Ingrid A. Beck, C. Mitchell, L. Frenkel, 2014, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

T69D/N pol mutation, human immunodeficiency virus type 1 RNA levels, and syncytium-inducing phenotype are associated with CD4 cell depletion during didanosine therapy.

V. Carey, R. Coombs, L. Frenkel, 2002, The Journal of infectious diseases.

Monitoring of HIV type 1 DNA load and drug resistance in peripheral blood mononuclear cells during suppressive antiretroviral therapy does not predict virologic failure.

Ingrid A. Beck, P. Krogstad, S. Nachman, 2012, AIDS research and human retroviruses.

Implementation of an interactive mobile application to pilot a rapid assay to detect HIV drug resistance mutations in Kenya

Eric Klavins, Parker S. Ruth, Barry R. Lutz, 2021, PLOS global public health.

Structured treatment interruptions (STIs) in HIV-1 infected pediatric populations increases interferon gamma production and reduces viremia.

W. Borkowsky, R. Yogev, L. Frenkel, 2008, Vaccine.

Yet another reason to treat HIV infection.

L. Frenkel, Thor A Wagner, 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Massively Parallel Sequencing Drug-Resistant Mutants by Use of Immunodeficiency Virus Type 1 Assay for Quantification of Human Validation of an Oligonucleotide Ligation

Roger E Bumgarner, Ingrid A. Beck, J. Mullins, 2014 .

Increasing HIV-1 pretreatment drug resistance among antiretroviral-naïve adults initiating treatment between 2006 and 2014 in Nairobi, Kenya

Ingrid A. Beck, B. Chohan, J. Kiarie, 2016, AIDS.

Observational study of effects of HIV Acquisition and Antiretroviral Treatment on Biomarkers of Systemic Immune Activation

P. Edlefsen, J. Lama, L. Frenkel, 2023, medRxiv : the preprint server for health sciences.

Itraconazole treatment of phaeohyphomycosis.

R. M. Tucker, P. Hoeprich, D. Stevens, 1990, Journal of the American Academy of Dermatology.

Cancer in the HIV-infected child.

L. Frenkel, R. Berkowitz, 1996, Pediatric dentistry.

Development of a novel codon-specific polymerase chain reaction for the detection of CXCR4-utilizing HIV type 1 subtype B.

P. Harrigan, R. Coombs, L. Frenkel, 2013, AIDS research and human retroviruses.

A Randomized Clinical Trial Evaluating the Management of Pre-Treatment HIV Drug Resistance by Oligonucleotide Ligation Assay

B. Chohan, J. Kiarie, R. Coombs, 2019 .

Antiretroviral prophylaxis for HIV prevention in heterosexual men and women.

J. Baeten, J. Tappero, D. Bangsberg, 2012, The New England journal of medicine.

Rapid, Near Point-of-Care Assay for HLA-B*57:01 Genotype Associated with Severe Hypersensitivity Reaction to Abacavir.

Parker S. Ruth, S. Ávila-Ríos, B. Lutz, 2021, AIDS research and human retroviruses.

Oral findings in asymptomatic (P-1) and symptomatic (P-2) HIV infected children.

C. Meyerowitz, L. Frenkel, R. Berkowitz, 1996, Pediatric dentistry.